Rajadhyaksha Girish Chandrakant, Meah Ameena
Department of Medicine, Topiwala National Medical College & B.Y.L. Nair Ch Hospital, Mumbai, Maharashtra, India.
Indian J Crit Care Med. 2018 Oct;22(10):711-717. doi: 10.4103/ijccm.IJCCM_505_17.
In a medical intensive care unit (MICU), many patients develop hemostatic abnormalities, ranging from abnormal clotting tests to frank bleeding. The aim of this study was to assess the etiology of diseases that present with bleeding, its common bleeding manifestations, incidence, MICU stay, mortality, and transfusion requirements in an Indian setup and also to assess if the Acute Physiology and Chronic Health Evaluation II (APACHE II) score can be used as a predictor for blood transfusion requirements.
Between July 2013 and August 2014, 200 patients with clinically significant bleeding admitted in the MICU were prospectively evaluated. Detailed history, examination, laboratory investigations, APACHE II score, and requirement of blood products were also noted. The endpoints were discharge or death.
The spectrum of diseases that presented with bleeding was 47 patients with malaria (23.5%) followed by 36 acute undifferentiated febrile illness (18.0%), 33 dengue (16.5%), 30 leptospirosis (15.0%), 31 acute fulminant hepatitis (15.5%), 14 sepsis (7.0%), and the rest nine miscellaneous causes. The most common bleeding manifestation observed was hematuria in 62/200 (31%). Among the patients studied, 126 expired (63%) and 74 survived (37%). Of the 200 patients, 48/200 (24%) received packed cells, 78/200 (39%) fresh frozen plasma, and 82/200 (41%) platelets.
Tropical diseases formed the majority of admissions with bleeding manifestations. Thrombocytopenia is an important marker to predict mortality and also has a significant association with MICU stay. APACHE II score was found to be a good predictor of blood transfusion requirements.
在医学重症监护病房(MICU)中,许多患者会出现止血异常,从凝血检查异常到明显出血不等。本研究的目的是评估印度地区出现出血症状的疾病病因、常见出血表现、发病率、在MICU的住院时间、死亡率和输血需求,同时评估急性生理与慢性健康状况评分系统II(APACHE II)评分是否可作为输血需求的预测指标。
2013年7月至2014年8月期间,对MICU收治的200例有临床显著出血症状的患者进行前瞻性评估。记录详细病史、体格检查、实验室检查、APACHE II评分及血液制品需求情况。观察终点为出院或死亡。
出现出血症状的疾病谱为:47例疟疾患者(23.5%),其次是36例急性未分化发热性疾病(18.0%)、33例登革热(16.5%)、30例钩端螺旋体病(15.0%)、31例急性暴发性肝炎(15.5%)、14例脓毒症(7.0%),其余9例为其他杂类病因。观察到的最常见出血表现为血尿,200例中有62例(31%)。在研究的患者中,126例死亡(63%),74例存活(37%)。200例患者中,48例(24%)接受了红细胞悬液,78例(39%)接受了新鲜冰冻血浆,82例(41%)接受了血小板。
热带疾病占出现出血症状入院患者的大多数。血小板减少是预测死亡率的重要指标,且与在MICU的住院时间有显著关联。发现APACHE II评分是输血需求的良好预测指标。